20th Annual Pediatric Endocrinology and Diabetes Symposium

Monday, November 15, 2021, 8:30 AM - 1:00 PM EST, Virtual


The past 20 years have seen advancement in the care of youth with diabetes and growth disorders. With this anniversary symposium, the Mount Sinai Division of Pediatric Endocrinology and Diabetes seeks to review the progress in the care of children with diabetes and growth disorders over the last 20 years and look forward to the upcoming 20 years. Participants will learn about pathophysiology, treatment goals and methods for care of children with diabetes and growth disorders, and will emerge more confident dealing with diabetes and endocrine challenges.

1. Identify the underlying etiologies of growth disorders and understand a systematic approach to genetic testing in the subgroup of patients with apparent genetic causes for short stature
2. Review the underlying etiologies of SGA and be able to identify patients
3. Recognize clinical evidence based advances in the treatment of type 1 and type 2 diabetes mellitus

Practicing Physician - $30.00

MSHS Allied Health Professional - $15.00

Resident/Fellow/Medical Student - Complimentary*

**PLEASE EMAIL A COPY OF YOUR HOSPITAL ID TO [email protected] TO RECEIVE A COMPLIMENTARY REGISTRATION CODE**

Cancellation Policy

All cancellation requests must be emailed to the CME office at [email protected] by October 19, 2020. No refunds will be issued for for this course.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance (1.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Monday, November 15, 2021

In collaboration with